Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$115.13M+8.8%$105.82M+17.8%$89.85M-0.9%$90.66M+1.5%$89.3M+4.1%
$7.85M+3.3%$7.6M+20.5%$6.31M+3.0%$6.13M-10.3%$6.83M+26.0%
$78.03M+11.8%$69.79M+21.3%$57.56M+3.5%$55.61M-0.7%$56.01M+3.4%
$15.04M+5.4%$14.26M+3.6%$13.77M-8.2%$15M+4.6%$14.34M-5.9%
$40.1M+5.1%$38.16M+16.1%$32.86M-11.2%$36.99M+8.3%$34.17M-21.0%
34.8%-1.2pp36.1%-0.5pp36.6%-4.2pp40.8%+2.5pp38.3%-12.2pp
$0.82+2.5%$0.80+15.9%$0.69-12.7%$0.79+6.8%$0.74-22.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is National Health Investors's revenue?
National Health Investors (NHI) generated $401.5M in revenue over the trailing twelve months, up 17.1% year over year.
Is National Health Investors profitable?
National Health Investors reported $148.1M in net income over the trailing twelve months, a 36.9% net margin.
What is National Health Investors's earnings per share?
National Health Investors's diluted EPS over the trailing twelve months is $3.10.
Where does National Health Investors's income statement data come from?
Every line is extracted from National Health Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.